Jefferies cuts Honeywell Aerospace price target on margin concerns

Jefferies cut its Honeywell Aerospace price target to $170 from $175 and lowered its 2027 EPS estimate 4% to $8.65 from $9.00, citing margin-sustainability concerns; its rating remains Hold. The firm projects 2027 margins of 23.8%, flat year over year, as labor, supply-chain and mix headwinds weigh on operating leverage. Q3 sales beat expectations by 2% and EBIT by 7%, while the company separately reported $2.21 adjusted EPS, $4.6B revenue and $500M free cash flow, and raised full-year EPS and second-half free-cash-flow guidance.

Analysis

The risk is less a single-quarter miss than the quality of the earnings base: pulled-forward aftermarket activity and tariff-related support helped reported performance, while the 2027 estimate assumes flat margins despite labor, supply-chain, mix and investment pressures. If those supports fade, operating leverage may not translate into EPS growth. The aftermarket pull-forward is primarily a timing risk—not proof of weaker end demand—but it raises the hurdle for the next quarter’s comparison. Raised company guidance and strong quarterly cash generation are counterweights, though one quarter does not establish that cash conversion or margin support is durable.

Near term, further estimate cuts may weigh on the stock even with shares near their 52-week low; the gap to Jefferies’ target is not a reliable valuation floor while earnings assumptions are moving down. Over 1–3 months, watch the next report for aftermarket order timing, organic growth, and whether tariff-related EBIT support persists. Over 6–18 months, sustained labor and supply-chain relief or a better mix could restore operating leverage; persistent bottlenecks and investment needs would undermine that case. Competitors such as GE Aerospace and RTX could benefit at the margin if Honeywell-specific execution limits delivery or aftermarket capture, but aerospace qualification and installed-base dynamics make rapid share transfer unlikely. The cautious view is falsified by stable or improving margins alongside organic growth that does not depend on timing benefits.

Key Decisions for Investors

• Do not buy solely on the apparent discount to the analyst target. Keep HONA at neutral/underweight pending evidence that earnings revisions have stabilized; the modestly negative signal does not justify an aggressive short on its own.
• For existing holders, use the next earnings release as the decision point: require confirmation that aftermarket pull-forward has not created a material subsequent-quarter gap and that EBIT margins are holding without unusual tariff or mix support.
• Watch for another 2027 EPS reduction, weaker organic growth, or margin deterioration as a catalyst to reduce exposure. Conversely, stable margins and unchanged estimates despite normalized aftermarket timing would falsify the cautious thesis.
• Do not treat the reported quarter’s free cash flow as a run rate. Verify working-capital contributions and full-year cash conversion before underwriting the raised cash-flow outlook.